These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease. Van Blercom N; Lasa A; Verger K; Masramón X; Sastre VM; Linazasoro G Clin Neuropharmacol; 2004; 27(3):124-8. PubMed ID: 15190235 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease. Stathis P; Konitsiotis S; Tagaris G; Peterson D; Mov Disord; 2011 Feb; 26(2):264-70. PubMed ID: 21412833 [TBL] [Abstract][Full Text] [Related]
8. Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. Rascol O; Bronzova J; Hauser RA; Lang AE; Sampaio C; Theeuwes A; van de Witte SV Parkinsonism Relat Disord; 2012 May; 18(4):370-6. PubMed ID: 22316635 [TBL] [Abstract][Full Text] [Related]
9. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. Fox SH; Metman LV; Nutt JG; Brodsky M; Factor SA; Lang AE; Pope LE; Knowles N; Siffert J Mov Disord; 2017 Jun; 32(6):893-903. PubMed ID: 28370447 [TBL] [Abstract][Full Text] [Related]
10. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029 [TBL] [Abstract][Full Text] [Related]
11. A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease. Herring WJ; Assaid C; Budd K; Vargo R; Mazenko RS; Lines C; Ellenbogen A; Verhagen Metman L Clin Neuropharmacol; 2017; 40(6):255-260. PubMed ID: 29059133 [TBL] [Abstract][Full Text] [Related]
12. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Berg D; Godau J; Trenkwalder C; Eggert K; Csoti I; Storch A; Huber H; Morelli-Canelo M; Stamelou M; Ries V; Wolz M; Schneider C; Di Paolo T; Gasparini F; Hariry S; Vandemeulebroecke M; Abi-Saab W; Cooke K; Johns D; Gomez-Mancilla B Mov Disord; 2011 Jun; 26(7):1243-50. PubMed ID: 21484867 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. Parkinson Study Group Arch Neurol; 2001 Oct; 58(10):1660-8. PubMed ID: 11594926 [TBL] [Abstract][Full Text] [Related]
14. Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Wolz M; Löhle M; Strecker K; Schwanebeck U; Schneider C; Reichmann H; Grählert X; Schwarz J; Storch A J Neural Transm (Vienna); 2010 Nov; 117(11):1279-86. PubMed ID: 20803300 [TBL] [Abstract][Full Text] [Related]
15. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Verhagen Metman L; Del Dotto P; van den Munckhof P; Fang J; Mouradian MM; Chase TN Neurology; 1998 May; 50(5):1323-6. PubMed ID: 9595981 [TBL] [Abstract][Full Text] [Related]